TrademarkDir
NOVAVAX
LIVE

Serial Number

97008365

Owner

NOVAVAX, INC.

Attorney

Caroline L Marsili

First Use Date

Nov 2, 2021

Filing Date

Sep 2, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

NOVAVAX Trademark

Serial Number: 97008365 • Registration: 6981969

NOVAVAX is a trademark filed by NOVAVAX, INC. on September 2, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NOVAVAX, INC. (151 trademarks)

8320 GUILFORD ROAD
COLUMBIA, MD 21046

Entity Type: 03

Trademark Details

Filing Date

September 2, 2021

Registration Date

February 14, 2023

First Use Anywhere

November 2, 2021

First Use in Commerce

November 2, 2021

Published for Opposition

June 14, 2022

Goods & Services

Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, vaccines, and clinical trials and post-market trials related to pharmaceuticals, biologics, and vaccines

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 12, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 12, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 12, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 12, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 12, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 12, 2025 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 4, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 4, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 4, 2024 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 14, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 14, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 12, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 11, 2023 CNPR
ASSIGNED TO EXAMINER
Nov 7, 2022 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Oct 24, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 24, 2022 AITU
USE AMENDMENT FILED
Oct 6, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 6, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 9, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 14, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 14, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 25, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 12, 2022 PREV
ASSIGNED TO LIE
May 9, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 6, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 6, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 6, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 6, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 31, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 31, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 31, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 31, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 16, 2021 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2021 NWOS
NEW APPLICATION ENTERED
Sep 6, 2021 NWAP

Related Trademarks

More from this Owner

CHOOSE TO PROTECT

CHOOSE TO PROTECT

CHOOSE TO PROTECT

CHOOSE TO PROTECT

ORDINARY IS EXTRAORDINARY

ORDINARY IS EXTRAORDINARY

ORDINARY IS EXTRAORDINARY

ORDINARY IS EXTRAORDINARY

RESVAX

RESVAX

RESVAX

RESVAX